Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients

被引：0
|
作者：
Judith Honing
Kirill V. Pavlov
Coby Meijer
Justin K. Smit
Wytske Boersma-van Ek
Arend Karrenbeld
Johannes G. M. Burgerhof
Frank A. E. Kruyt
John Th. M. Plukker
机构：
[1] University of Groningen,Department of Surgery
[2] University Medical Center Groningen,Department of Gastroenterology and Hepatology
[3] University of Groningen,Department of Medical Oncology
[4] University Medical Center Groningen,Department of Pathology
[5] University of Groningen,Department of Epidemiology
[6] University Medical Center Groningen,undefined
[7] University of Groningen,undefined
[8] University Medical Center Groningen,undefined
[9] University of Groningen,undefined
[10] University Medical Center Groningen,undefined
来源：
Annals of Surgical Oncology | 2014年 / 21卷
关键词：
Overall Survival; Cancer Stem Cell; Esophageal Carcinoma; SOX2 Expression; Poor Overall Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：657 / 664
页数：7
相关论文
共 50 条
  • [1] Loss of CD44 and SOX2 Expression is Correlated with a Poor Prognosis in Esophageal Adenocarcinoma Patients
    Honing, Judith
    Pavlov, Kirill V.
    Meijer, Coby
    Smit, Justin K.
    Boersma-van Ek, Wytske
    Karrenbeld, Arend
    Burgerhof, Johannes G. M.
    Kruyt, Frank A. E.
    Plukker, John Th M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S657 - S664
  • [2] Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma
    Jung, Woon Yong
    Kang, Youngran
    Lee, Hyunjoo
    Mok, Young-Jae
    Kim, Han Kyeom
    Kim, Aeree
    Kim, Baek-hui
    [J]. HISTOPATHOLOGY, 2013, 63 (04) : 474 - 481
  • [3] CD44 variant 6 (CD44v6) expression is associated with poor prognosis in superficial esophageal adenocarcinoma (SADC).
    Ormsby, AH
    Rice, TW
    Rybicki, LA
    Goldblum, JR
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A659 - A659
  • [4] CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy
    Honing, Judith
    Pavlov, Kirill V.
    Mul, Veronique E. M.
    Karrenbeld, Arend
    Meijer, Coby
    Faiz, Zohra
    Smit, Justin K.
    Hospers, Geke A. P.
    Burgerhof, Johannes G. M.
    Kruyt, Frank A. E.
    Kleibeuker, Jan H.
    Plukker, John T. M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 117 (01) : 152 - 158
  • [5] SOX2 loss predicts adverse survival of esophageal adenocarcinoma patients
    Ten Kate, F.
    van Olphen, S.
    Bruno, M.
    Wijnhoven, B.
    van Lanschot, J.
    Looijenga, L.
    Fitzgerald, R.
    Biermann, K.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S2 - S2
  • [6] Clinicopathologic Significance of Sox2, CD44 and CD44v6 Expression in Intrahepatic Cholangiocarcinoma
    Gu, Mi Jin
    Jang, Byung Ik
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (03) : 655 - 660
  • [7] Decreased Expression of SOX7 is Correlated with Poor Prognosis in Lung Adenocarcinoma Patients
    Li, Bing
    Ge, Zhiping
    Song, Shipeng
    Zhang, Shengbin
    Yan, Hong
    Huang, Boyun
    Zhang, Yangde
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (04) : 1039 - 1045
  • [8] High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
    Si, Daolin
    Yin, Fei
    Peng, Jing
    Zhang, Guangying
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 769 - 775
  • [9] CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
    Xueyuan Cao
    Donghui Cao
    MeiShan Jin
    Zhifang Jia
    Fei Kong
    Hongxi Ma
    Yinping Wang
    Jing Jiang
    [J]. BMC Gastroenterology, 14
  • [10] CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
    Cao, Xueyuan
    Cao, Donghui
    Jin, MeiShan
    Jia, Zhifang
    Kong, Fei
    Ma, Hongxi
    Wang, Yinping
    Jiang, Jing
    [J]. BMC GASTROENTEROLOGY, 2014, 14
12345